# Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy

Source: https://onco.cc/trials/nct01091974/  
OnCo record `nct01091974` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Cognitive behavioural therapy for insomnia in Breast cancer, run by University of Rochester, completed.

## Summary

Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy is a phase 2 interventional study registered as NCT01091974 by University of Rochester, with 138 participants recorded, started 2008-02 and reaching its primary completion in 2013-04. Interventions recorded: armodafinil, Placebo Comparator, CBT-I. Conditions recorded: Insomnia, Fatigue, Breast Cancer.

Linked to the technology Cognitive behavioural therapy for insomnia because the registry names it ("cbt i") among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT01091974
- Phase: 2
- Setting: Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
- Sponsor: University of Rochester
- Enrolled: 138

## Sources

- ClinicalTrials.gov NCT01091974: https://clinicaltrials.gov/study/NCT01091974

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/)
- technologies: [Cognitive behavioural therapy for insomnia (CBT-I)](https://onco.cc/technologies/cbt-insomnia-cancer/)

---
JSON: https://onco.cc/api/v1/entities/nct01091974.json